To corroborate our findings and further explore a potential role of microglial inflammasome activation in other mouse models of Aβ-induced neuropathology, we extended our studies to the widely used APP/PS1 mouse model of AD. This evidence concerns the gene PSEN1 and Alzheimer disease.